TCW Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,703
| Closed | -$280K | – | 650 |
|
|
2026
Q1 | $280K | Buy |
3,703
+179
| +5% | +$13.5K | ﹤0.01% | 586 |
|
|
2025
Q4 | $263K | Buy |
+3,524
| New | +$257K | ﹤0.01% | 599 |
|
|
2018
Q1 | – | Sell |
-12,802
| Closed | -$547K | – | 377 |
|
|
2017
Q4 | $547K | Buy |
+12,802
| New | +$511K | ﹤0.01% | 331 |
|
|
2017
Q1 | – | Sell |
-20,500
| Closed | -$822K | – | 490 |
|
|
2016
Q4 | $822K | Hold |
20,500
| – | – | 0.01% | 533 |
|
|
2016
Q3 | $796K | Buy |
20,500
+2,700
| +15% | +$102K | 0.01% | 533 |
|
|
2016
Q2 | $616K | Buy |
17,800
+550
| +3% | +$19K | ﹤0.01% | 591 |
|
|
2016
Q1 | $595K | Buy |
+17,250
| New | +$602K | ﹤0.01% | 603 |
|
|
2015
Q1 | – | Sell |
-143,878
| Closed | -$3.85M | – | 752 |
|
|
2014
Q4 | $3.85M | Buy |
143,878
+2,066
| +1% | +$53.3K | 0.02% | 465 |
|
|
2014
Q3 | $3.45M | Sell |
141,812
-279,156
| -66% | -$7.05M | 0.01% | 577 |
|
|
2014
Q2 | $10.7M | Sell |
420,968
-1,662,376
| -80% | -$38.8M | 0.04% | 324 |
|
|
2014
Q1 | $44.8M | Sell |
2,083,344
-423,414
| -17% | -$9.13M | 0.19% | 110 |
|
|
2013
Q4 | $56M | Sell |
2,506,758
-1,797,593
| -42% | -$39.6M | 0.24% | 98 |
|
|
2013
Q3 | $88.9M | Buy |
4,304,351
+88,485
| +2% | +$1.88M | 0.41% | 73 |
|
|
2013
Q2 | $81.4M | Buy |
+4,215,866
| New | +$88.1M | 0.4% | 75 |
|
Other funds holding HOLX
TCW Group's HOLX Position: Q2 2026 in Review
TCW Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,703 shares — an estimated $280K sold.
TCW Group first reported a position in HOLX in Q2 2013 and held it in 14 quarters. The position peaked at $88.9M in Q3 2013. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- TCW Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- TCW Group sold 3,703 Hologic shares in Q2 2026, an estimated $280K.
- TCW Group first reported a position in Hologic in Q2 2013 and held it in 14 quarters.
- TCW Group's Hologic position peaked at $88.9M in Q3 2013.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.